ストックスクリーナーアプリを入手
11.54
4.53%
0.50
前日終値:
$11.04
開ける：
$11.25
24時間の取引高:
661.95K
Relative Volume:
2.33
時価総額：
$253.92M
収益：
$52.55M
当期純損益:
$-23.69M
株価収益率:
-12.28
EPS:
-0.94
ネットキャッシュフロー:
$-15.29M
1週間 パフォーマンス:
+5.29%
1か月 パフォーマンス:
+18.48%
6か月 パフォーマンス:
+150.87%
1年 パフォーマンス:
+327.41%
1日の値動き範囲:
$11.06
$11.75
1週間の範囲:
$10.78
$11.75
52週間の値動き範囲:
$2.38
$11.75
Exagen Inc Stock (XGN) Company Profile
XGN を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
XGN
Exagen Inc
|
11.54 | 242.92M | 52.55M | -23.69M | -15.29M | -0.94 |
|
TMO
Thermo Fisher Scientific Inc
|
525.83 | 198.09B | 43.21B | 6.58B | 6.17B | 17.28 |
|
DHR
Danaher Corp
|
206.15 | 146.89B | 24.01B | 3.41B | 4.86B | 4.7082 |
|
IDXX
Idexx Laboratories Inc
|
636.91 | 50.67B | 4.04B | 985.66M | 774.34M | 12.01 |
|
A
Agilent Technologies Inc
|
138.04 | 39.19B | 6.79B | 1.22B | 1.09B | 4.2644 |
|
IQV
Iqvia Holdings Inc
|
204.76 | 34.64B | 15.70B | 1.24B | 2.01B | 6.9036 |
Exagen Inc Stock (XGN) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-09-11 | 開始されました | B. Riley Securities | Buy |
| 2025-07-30 | アップグレード | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2025-07-23 | 開始されました | Craig Hallum | Buy |
| 2022-08-05 | ダウングレード | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2021-10-15 | 再開されました | Cowen | Outperform |
| 2021-04-15 | 開始されました | Canaccord Genuity | Buy |
| 2020-11-10 | 開始されました | KeyBanc Capital Markets | Overweight |
| 2020-10-08 | 開始されました | BTIG Research | Buy |
| 2020-06-02 | 再開されました | Cantor Fitzgerald | Overweight |
| 2019-10-14 | 開始されました | Cantor Fitzgerald | Overweight |
| 2019-10-14 | 開始されました | Cowen | Outperform |
| 2019-10-14 | 開始されました | William Blair | Outperform |
すべてを表示
Exagen Inc (XGN) 最新ニュース
Has Exagen Inc. formed a bullish divergenceJuly 2025 Analyst Calls & Fast Entry High Yield Tips - newser.com
Strategies to average down on Exagen Inc.July 2025 Technicals & Technical Pattern Alert System - newser.com
Exagen (XGN) Gets Maintained 'Overweight' Rating by Keybanc Anal - GuruFocus
Detecting support and resistance levels for Exagen Inc.Rate Hike & Low Drawdown Investment Strategies - newser.com
How to build a custom watchlist for Exagen Inc.Price Action & Safe Investment Capital Preservation Plans - newser.com
Will Exagen Inc. benefit from macro trendsQuarterly Portfolio Report & Weekly Setup with ROI Potential - newser.com
How Exagen Inc. stock compares to market leadersPortfolio Return Summary & Expert Approved Momentum Trade Ideas - newser.com
Will Exagen Inc. stock split attract more investorsEarnings Miss & Daily Volume Surge Trade Alerts - newser.com
Will Exagen Inc. stock recover faster than peersMarket Trend Report & Intraday High Probability Setup Alerts - newser.com
What to do if you’re stuck in Exagen Inc.Watch List & Verified Technical Trade Signals - newser.com
Should you hold or exit Exagen Inc. nowJuly 2025 Trade Ideas & Real-Time Volume Trigger Notifications - newser.com
Analyzing Exagen Inc. with multi timeframe chartsMarket Sentiment Summary & Smart Investment Allocation Tips - newser.com
Earnings visualization tools for Exagen Inc.Market Risk Analysis & High Return Stock Watch Alerts - newser.com
Custom strategy builders for tracking Exagen Inc.Trade Exit Summary & Daily Technical Stock Forecast Reports - newser.com
Will Exagen Inc. stock maintain momentum in 20252025 Market Sentiment & Safe Entry Zone Tips - newser.com
Is Exagen Inc. (E08A) stock testing key supportJuly 2025 Levels & Real-Time Chart Breakout Alerts - newser.com
Exagen’s (XGN) “Sell (D-)” Rating Reiterated at Weiss Ratings - Defense World
Is Exagen Inc. stock ready for a breakoutInflation Watch & Weekly Stock Breakout Alerts - newser.com
Does Exagen Inc. show high probability of reboundNew Guidance & Safe Entry Point Alerts - newser.com
Exagen (NASDAQ:XGN) Earns Sell (D-) Rating from Weiss Ratings - MarketBeat
What analysts say about Exagen Inc stockMoving Average Crossovers & Affordable Investment Tips - earlytimes.in
Can Exagen Inc. recover in the next quarterBond Market & Weekly Momentum Stock Picks - newser.com
Exagen Inc. (NASDAQ:XGN) Given Average Recommendation of "Moderate Buy" by Analysts - MarketBeat
Exagen Inc. recovery potential after sell offBond Market & Reliable Price Breakout Signals - newser.com
Exagen Inc Stock Analysis and ForecastBullish Engulfing Patterns & Small Budget Capital Investment - earlytimes.in
Exagen Inc. (XGN) Reports Q1 Loss, Tops Revenue Estimates - MSN
Is Exagen Inc. stock a bargain at current levelsQuarterly Investment Review & Real-Time Volume Spike Alerts - newser.com
Will Exagen Inc. (E08A) stock recover faster than industryMarket Sentiment Review & Real-Time Volume Trigger Notifications - newser.com
Is Exagen Inc. (E08A) stock supported by free cash flowJuly 2025 Levels & Technical Buy Zone Confirmations - newser.com
What drives Exagen Inc stock priceUtilities Sector Analysis & Crush the Market with Breakout Winners - earlytimes.in
With 38% stake, Exagen Inc. (NASDAQ:XGN) seems to have captured institutional investors' interest - Yahoo Finance
Can Exagen Inc. (E08A) stock test all time highs2025 Growth vs Value & Reliable Breakout Forecasts - newser.com
Exagen Inc (XGN) 財務データ
収益
当期純利益
現金流量
EPS
Exagen Inc (XGN) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| NMSIC Co-Investment Fund, L.P. | 10% Owner |
Mar 25 '25 |
Sale |
3.30 |
350,000 |
1,155,000 |
1,758,958 |
| NMSIC Co-Investment Fund, L.P. | 10% Owner |
Nov 20 '24 |
Sale |
3.30 |
200,000 |
660,040 |
2,108,958 |
| Black Jeffrey G. | Chief Financial Officer |
Nov 15 '24 |
Buy |
2.98 |
22,298 |
66,448 |
274,492 |
| ABALLI JOHN | President and CEO |
Nov 14 '24 |
Buy |
2.81 |
24,305 |
68,297 |
689,799 |
0.95%
1.43%
大文字化:
|
ボリューム (24 時間):